Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
FRSX Quote, Financials, Valuation and Earnings
Last price:
$1.24
Seasonality move
:
20.91%
Day range:
$0.94 - $1.27
52-week range:
$0.57 - $1.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
40.50x
P/B ratio:
2.42x
Volume:
11.7M
Avg. volume:
847.9K
1-year change:
7.3%
Market cap:
$19.2M
Revenue:
$497K
EPS (TTM):
-$0.85
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $120K | $550K | $497K | |
| Revenue Growth (YoY) | -- | -- | -- | 358.33% | -9.64% | |
| Cost of Revenues | -- | -- | $67K | $252K | $143K | |
| Gross Profit | -- | -- | $53K | $298K | $354K | |
| Gross Profit Margin | -- | -- | 44.17% | 54.18% | 71.23% | |
| R&D Expenses | $10.2M | $8.6M | $10.2M | $11.5M | $11.6M | |
| Selling, General & Admin | $4.8M | $4.3M | $5.8M | $6.2M | $5.1M | |
| Other Inc / (Exp) | -$563K | -$2.6M | $4K | -$4.4M | -$2.8M | |
| Operating Expenses | $15M | $12.8M | $16M | $17.8M | $16.6M | |
| Operating Income | -$15M | -$12.8M | -$15.9M | -$17.5M | -$16.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$15.4M | -$15.4M | -$15M | -$21.7M | -$18.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$15.4M | -$15.4M | -$15M | -$21.7M | -$18.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15.4M | -$15.4M | -$15M | -$21.7M | -$18.4M | |
| Basic EPS (Cont. Ops) | -$3.00 | -$2.10 | -$1.50 | -$2.10 | -$1.80 | |
| Diluted EPS (Cont. Ops) | -$3.00 | -$2.10 | -$1.50 | -$2.10 | -$1.80 | |
| Weighted Average Basic Share | $5M | $7.3M | $10.7M | $10.8M | $11M | |
| Weighted Average Diluted Share | $5M | $7.3M | $10.7M | $10.8M | $11M | |
| EBITDA | -$14.8M | -$12.6M | -$15.8M | -$17.2M | -$16M | |
| EBIT | -$15M | -$12.8M | -$15.9M | -$17.5M | -$16.3M | |
| Revenue (Reported) | -- | -- | $120K | $550K | $497K | |
| Operating Income (Reported) | -$15M | -$12.8M | -$15.9M | -$17.5M | -$16.3M | |
| Operating Income (Adjusted) | -$15M | -$12.8M | -$15.9M | -$17.5M | -$16.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $40K | $203K | $304K | $111K | |
| Revenue Growth (YoY) | -- | -- | 407.5% | 49.75% | -63.49% | |
| Cost of Revenues | -- | $35K | $91K | $83K | $76K | |
| Gross Profit | -- | $5K | $112K | $221K | $35K | |
| Gross Profit Margin | -- | 12.5% | 55.17% | 72.7% | 31.53% | |
| R&D Expenses | $2.2M | $2.4M | $3M | $2.9M | $2.4M | |
| Selling, General & Admin | $1.2M | $1.3M | $1.4M | $1.3M | $984K | |
| Other Inc / (Exp) | -$655K | -- | -- | -- | -- | |
| Operating Expenses | $3.4M | $3.7M | $4.4M | $4.2M | $3.4M | |
| Operating Income | -$3.4M | -$3.7M | -$4.3M | -$4M | -$3.4M | |
| Net Interest Expenses | -- | $54K | $1.4M | $209K | -- | |
| EBT. Incl. Unusual Items | -$4M | -$3.8M | -$5.7M | -$4.2M | -$3.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$4M | -$3.8M | -$5.7M | -$4.2M | -$3.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4M | -$3.8M | -$5.7M | -$4.2M | -$3.3M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.35 | -$0.53 | -$0.39 | -$0.22 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.35 | -$0.53 | -$0.39 | -$0.22 | |
| Weighted Average Basic Share | $8.6M | $10.8M | $10.8M | $10.8M | $15.3M | |
| Weighted Average Diluted Share | $8.6M | $10.8M | $10.8M | $10.8M | $15.3M | |
| EBITDA | -$3.3M | -$3.7M | -$4.2M | -$3.9M | -$3.3M | |
| EBIT | -$3.4M | -$3.7M | -$4.3M | -$4M | -$3.4M | |
| Revenue (Reported) | -- | $40K | $203K | $304K | $111K | |
| Operating Income (Reported) | -$3.4M | -$3.7M | -$4.3M | -$4M | -$3.4M | |
| Operating Income (Adjusted) | -$3.4M | -$3.7M | -$4.3M | -$4M | -$3.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $531K | -- | $473K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $240K | -- | $187K | |
| Gross Profit | -- | -- | $291K | $310K | $286K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.6M | $9.7M | $11.1M | $12.2M | $9.4M | |
| Selling, General & Admin | $3.7M | $5.4M | $6.2M | $5.7M | $3.7M | |
| Other Inc / (Exp) | -$2.4M | -$634K | -- | -- | -- | |
| Operating Expenses | $13.3M | $15.1M | $17.3M | $17.8M | $13.1M | |
| Operating Income | -$13.3M | -$15.1M | -$17M | -$17.5M | -$12.8M | |
| Net Interest Expenses | -- | $54K | $4.6M | -- | -- | |
| EBT. Incl. Unusual Items | -$15.7M | -$15.3M | -$21.6M | -$18.7M | -$11.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$15.7M | -$15.3M | -$21.6M | -$18.7M | -$11.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$15.7M | -$15.3M | -$21.6M | -$18.7M | -$11.6M | |
| Basic EPS (Cont. Ops) | -$2.69 | -$1.45 | -$2.01 | -$1.77 | -$0.85 | |
| Diluted EPS (Cont. Ops) | -$2.69 | -$1.45 | -$2.01 | -$1.77 | -$0.85 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$13M | -$14.9M | -$16.8M | -$17.3M | -$12.6M | |
| EBIT | -$13.3M | -$15.1M | -$17M | -$17.5M | -$12.8M | |
| Revenue (Reported) | -- | -- | $531K | -- | $473K | |
| Operating Income (Reported) | -$13.3M | -$15.1M | -$17M | -$17.5M | -$12.8M | |
| Operating Income (Adjusted) | -$13.3M | -$15.1M | -$17M | -$17.5M | -$12.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $40K | $451K | $359K | $335K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $35K | $208K | $104K | $148K | |
| Gross Profit | -- | $5K | $243K | $255K | $187K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.4M | $7.5M | $8.5M | $9.2M | $7M | |
| Selling, General & Admin | $3.2M | $4.3M | $4.7M | $4.1M | $2.7M | |
| Other Inc / (Exp) | -$2M | -- | -- | -- | -- | |
| Operating Expenses | $9.6M | $11.8M | $13.2M | $13.2M | $9.7M | |
| Operating Income | -$9.6M | -$11.8M | -$12.9M | -$13M | -$9.5M | |
| Net Interest Expenses | -- | $54K | $7.4M | $1.9M | -- | |
| EBT. Incl. Unusual Items | -$11.4M | -$11.3M | -$17.9M | -$14.9M | -$8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$11.4M | -$11.3M | -$17.9M | -$14.9M | -$8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.4M | -$11.3M | -$17.9M | -$14.9M | -$8M | |
| Basic EPS (Cont. Ops) | -$1.84 | -$1.07 | -$1.66 | -$1.41 | -$0.62 | |
| Diluted EPS (Cont. Ops) | -$1.84 | -$1.07 | -$1.66 | -$1.41 | -$0.62 | |
| Weighted Average Basic Share | $20.5M | $31.9M | $32.3M | $32.4M | $46M | |
| Weighted Average Diluted Share | $20.5M | $31.9M | $32.3M | $32.4M | $46M | |
| EBITDA | -$9.4M | -$11.7M | -$12.8M | -$12.8M | -$9.3M | |
| EBIT | -$9.6M | -$11.8M | -$12.9M | -$13M | -$9.5M | |
| Revenue (Reported) | -- | $40K | $451K | $359K | $335K | |
| Operating Income (Reported) | -$9.6M | -$11.8M | -$12.9M | -$13M | -$9.5M | |
| Operating Income (Adjusted) | -$9.6M | -$11.8M | -$12.9M | -$13M | -$9.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.8M | $38.8M | $28.1M | $19.2M | $15.6M | |
| Short Term Investments | $5.3M | $5.2M | $17.5M | $7.2M | $474K | |
| Accounts Receivable, Net | -- | -- | -- | -- | $308K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $339K | $197K | $284K | $380K | $147K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.7M | $44.4M | $46.4M | $27.3M | $17M | |
| Property Plant And Equipment | $1.9M | $1.5M | $3.1M | $2.8M | $2.3M | |
| Long-Term Investments | $6.7M | $4M | $4M | $2.8M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $19.3M | $49.9M | $53.5M | $32.9M | $19.3M | |
| Accounts Payable | $498K | $391K | $253K | $315K | $136K | |
| Accrued Expenses | $208K | $428K | $241K | $299K | $163K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $411K | $427K | $587K | $527K | $468K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2M | $2M | $2.7M | $2.6M | $2.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3M | $2.9M | $4.8M | $4.1M | $3.3M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $16.3M | $47M | $48.4M | $28.3M | $15.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $74K | $228K | $453K | $603K | |
| Total Equity | $16.3M | $47M | $48.6M | $28.8M | $16M | |
| Total Liabilities and Equity | $19.3M | $49.9M | $53.5M | $32.9M | $19.3M | |
| Cash and Short Terms | $10.1M | $44M | $45.6M | $26.4M | $16.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.4M | $32.3M | $12.4M | $14.1M | $8.8M | |
| Short Term Investments | $5.2M | $16.7M | $17.7M | $2K | $15K | |
| Accounts Receivable, Net | -- | -- | -- | -- | $430K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $15M | $49.7M | $31.3M | $15.1M | $10M | |
| Property Plant And Equipment | $1.6M | $2.3M | $2.9M | $2.5M | $2M | |
| Long-Term Investments | $4.7M | $4M | $1.5M | $1.2M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $21.3M | $56M | $35.7M | $18.8M | $12.1M | |
| Accounts Payable | $188K | $278K | $228K | $251K | $281K | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $401K | $430K | $537K | $443K | $314K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7M | $2.6M | $2M | $2.3M | $2.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.6M | $4.1M | $3.6M | $3.6M | $3.5M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $42K | $181K | $403K | $585K | $648K | |
| Total Equity | $18.8M | $51.9M | $32.2M | $15.2M | $8.6M | |
| Total Liabilities and Equity | $21.3M | $56M | $35.7M | $18.8M | $12.1M | |
| Cash and Short Terms | $14.6M | $49M | $30.2M | $14.1M | $8.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.4M | -$15.4M | -$15M | -$21.7M | -$18.4M | |
| Depreciation & Amoritzation | $259K | $254K | $159K | $218K | $263K | |
| Stock-Based Compensation | $1.6M | $1.2M | $2.5M | $1.8M | $1.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$308K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$11.9M | -$11.5M | -$12.1M | -$17.1M | -$14.9M | |
| Capital Expenditures | -- | -- | $235K | $313K | $124K | |
| Cash Acquisitions | -- | -- | -- | -$715K | -- | |
| Cash From Investing | $7.2M | $85K | -$12.6M | $9M | $7.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $6.5M | $45.3M | $14.2M | -- | $4.2M | |
| Beginning Cash (CF) | $3.2M | $4.8M | $38.8M | $28.2M | $19.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.9M | $33.9M | -$10.5M | -$8.1M | -$3.7M | |
| Ending Cash (CF) | $4.8M | $38.8M | $28.2M | $19.3M | $15.7M | |
| Levered Free Cash Flow | -$12M | -$11.5M | -$12.4M | -$17.4M | -$15.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4M | -$3.8M | -$5.7M | -$4.2M | -$3.3M | |
| Depreciation & Amoritzation | $61K | $39K | $55K | $64K | $45K | |
| Stock-Based Compensation | $560K | $379K | $434K | $425K | $252K | |
| Change in Accounts Receivable | -$135K | -$151K | -$428K | -$68K | -$362K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.7M | -$3.2M | -$5M | -$3.4M | -$3.3M | |
| Capital Expenditures | -- | $57K | $33K | $14K | $23K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.9M | $11.7M | -$7.3M | $648K | -$23K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $98K | |
| Cash From Financing | -$153K | -- | -- | $137K | $143K | |
| Beginning Cash (CF) | $10.3M | $23.9M | $25.1M | $17.1M | $12.1M | |
| Foreign Exchange Rate Adjustment | $19K | -$25K | -$323K | -$367K | $64K | |
| Additions / Reductions | -$936K | $8.5M | -$12.3M | -$2.6M | -$3.2M | |
| Ending Cash (CF) | $9.4M | $32.3M | $12.5M | $14.2M | $8.9M | |
| Levered Free Cash Flow | -$2.8M | -$3.3M | -$5M | -$3.4M | -$3.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.7M | -$15.3M | -$21.6M | -$18.7M | -$11.6M | |
| Depreciation & Amoritzation | $258K | $181K | $201K | $246K | $227K | |
| Stock-Based Compensation | $1.3M | $2.3M | $1.8M | $1.6M | $794K | |
| Change in Accounts Receivable | $469K | -$441K | -$66K | $634K | -$836K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$11.6M | -$12M | -$16.3M | -$15.3M | -$12M | |
| Capital Expenditures | -- | $57K | $399K | $146K | $64K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $2.9M | -$11.7M | -$2.4M | $17.6M | $1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $12.9M | $46.5M | -- | $137K | $4.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.3M | $22.8M | -$18.7M | $2.4M | -$6.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$11.6M | -$12.1M | -$16.7M | -$15.4M | -$12.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.4M | -$11.3M | -$17.9M | -$14.9M | -$8M | |
| Depreciation & Amoritzation | $192K | $119K | $161K | $189K | $153K | |
| Stock-Based Compensation | $910K | $2M | $1.4M | $1.2M | $535K | |
| Change in Accounts Receivable | $167K | -$274K | -$340K | $294K | -$234K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.5M | -$9M | -$13.1M | -$11.3M | -$8.4M | |
| Capital Expenditures | -- | $57K | $282K | $115K | $55K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $111K | -$11.7M | -$1.5M | $7.1M | $1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $0 | |
| Cash From Financing | $12.9M | $14.2M | -- | $137K | $45K | |
| Beginning Cash (CF) | $17.7M | $94M | $80.1M | $57.4M | $42.6M | |
| Foreign Exchange Rate Adjustment | $36K | $47K | -$1M | -$982K | -$198K | |
| Additions / Reductions | $4.5M | -$6.5M | -$14.6M | -$4.1M | -$6.6M | |
| Ending Cash (CF) | $22.3M | $87.6M | $64.5M | $52.3M | $35.8M | |
| Levered Free Cash Flow | -$8.6M | -$9.1M | -$13.4M | -$11.4M | -$8.5M | |
Get FRSX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FRSX
Sector
P/E ratio
--
16.83x
PEG ratio
--
0.22x
P/B ratio
2.42x
1.45x
Price / LTM sales
40.50x
0.71x
Growth Metrics
FRSX
Sector
Revenue growth
-63.49%
0.14%
Earnings growth
--
--
Revenue (5-year growth)
--
3.45%
Earnings forecast
--
$0.30
Profitability
FRSX
Sector
Profitability FY 2023
$354K
$503.7M
Return on invested capital
-87.86%
5.17%
Return on assets
-68.86%
3.13%
Return on equity
-87.86%
7.63%
Earnings Date
Last Earnings Date
Nov
29
Next Earnings Date
Mar
27
Estimated Next Earnings Date
Feb
28
Balance Sheet
FRSX
Sector
Total cash
$8.9M
$157.7M
Short term investments
$474K
$60.7M
Total assets
$19.3M
$1.7B
Long term debt
--
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
